Abstract:Motivation: Currently there are no curative anticancer drugs, and drug resistance is often acquired after drug treatment. One of the reasons is that cancers are complex diseases, regulated by multiple signaling pathways and cross talks among the pathways. It is expected that drug combinations can reduce drug resistance and improve patients’ outcomes. In clinical practice, the ideal and feasible drug combinations are combinations of existing Food and Drug Administration-approved drugs or bioactive compounds that are already used on patients or have entered clinical trials and passed safety tests. These drug combinations could directly be used on patients with less concern of toxic effects. However, there is so far no effective computational approach to search effective drug combinations from the enormous number of possibilities. Results: In this study, we propose a novel systematic computational tool DrugComboRanker to prioritize synergistic drug combinations and uncover their mechanisms of action. We first build a drug functional network based on their genomic profiles, and partition the network into numerous drug network communities by using a Bayesian non-negative matrix factorization approach. As drugs within overlapping community share common mechanisms of action, we next uncover potential targets of drugs by applying a recommendation system on drug communities. We meanwhile build disease-specific signaling networks based on patients’ genomic profiles and interactome data. We then identify drug combinations by searching drugs whose targets are enriched in the complementary signaling modules of the disease signaling network. The novel method was evaluated on lung adenocarcinoma and endocrine receptor positive breast cancer, and compared with other drug combination approaches. These case studies discovered a set of effective drug combinations top ranked in our prediction list, and mapped the drug targets on the disease signaling network to highlight the mechanisms of action of the drug combinations. Availability and implementation: The program is available on request. Contact: stwong@tmhs.org

DrugComboRanker: Drug Combination Discovery Based on Target Network Analysis

Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations

Personalized Anti-Cancer Drug Combination Prediction by an Integrated Multi-level Network

Prediction of Synergistic Anti-Cancer Drug Combinations Based on Drug Target Network and Drug Induced Gene Expression Profiles

Neighbor Communities in Drug Combination Networks Characterize Synergistic Effect.

Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer

Anticancer Target Combinations: Network-Informed Signaling-Based Approach to Discovery

Predicting drug synergy using a network propagation inspired machine learning framework

DrugCombDB: a Comprehensive Database of Drug Combinations Toward Network Medicine and Combination Therapy

Exploring Drug Combinations in Genetic Interaction Network

A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results

Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study

Predicting Effective Drug Combinations for Cancer Treatment Using a Graph-Based Approach

Drug combination prediction for cancer treatment using disease-specific drug response profiles and single-cell transcriptional signatures

A network-based trans-omics approach for predicting synergistic drug combinations

Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

DrugCombDB: a Comprehensive Database of Drug Combinations Toward the Discovery of Combinatorial Therapy

SynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction

Prediction of Synergistic Drug Combinations for Prostate Cancer by Transcriptomic and Network Characteristics

Natural product based anticancer drug combination discovery assisted by deep learning and network analysis

SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction